scholarly journals TCT-37: ABSORB Cohort B Trial: 9 Months Clinical Results of the Evaluation of the Bioresorbable Everolimus-Eluting Vascular Scaffold (BVS) in the Treatment of Patients with de Novo Native Coronary Artery Lesions

2010 ◽  
Vol 56 (13) ◽  
pp. B9
Sign in / Sign up

Export Citation Format

Share Document